Pharma Industry Finland elects board
This article was originally published in Scrip
Pharma Industry Finland (PIF) has elected a new board. Ilpo Tolonen, managing director of MSD Finland became its new chairman, and Novartis Finland's MD Antti Viitanen and Orion Pharma's director Sari Kailanko were elected Mr Tolonen's first and second deputies respectively. Other board members are Leif Jokinen of H. Lundbeck, Jyrki Liljeroos of Santen, Jaakko Linna of Leiras Finland, Jyrki Lonnfors of AstraZeneca, Liisa Nuuros of Bayer, Harry Rastedt of GlaxoSmithKline, Ari Ronka of Ferring Laakkeet, Markku Santonen of Amgen and Ove Uljas of Pfizer. PIF's managing director, Suvi-Anne Siimes, was appointed the board secretary.